DOI QR코드

DOI QR Code

Failure patterns of cervical lymph nodes in metastases of unknown origin according to target volume

  • Kim, Dong-Yun (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Heo, Dae Seog (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Keam, Bhumsuk (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Ock, Chan Young (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Ahn, Soon Hyun (Department of Otorhinolaryngology, Seoul National University College of Medicine) ;
  • Kim, Ji-hoon (Department of Radiology, Seoul National University College of Medicine) ;
  • Jung, Kyeong Cheon (Department of Pathology, Seoul National University College of Medicine) ;
  • Kim, Jin Ho (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Wu, Hong-Gyun (Department of Radiation Oncology, Seoul National University College of Medicine)
  • 투고 : 2020.02.28
  • 심사 : 2020.03.26
  • 발행 : 2020.03.31

초록

Purpose: This study was aim to evaluate the patterns of failure according to radiotherapy (RT) target volume for cervical lymph nodes in metastases of unknown primary origin in head and neck region (HNMUO). Materials and Methods: Sixty-two patients with HNMUO between 1998 and 2016 were retrospectively reviewed. We analyzed the clinical outcomes and primary site failure depending on the radiation target volume. The target volume was classified according to whether the potential head and neck mucosal sites were included and whether the neck node was treated involved side only or bilaterally. Results: Potential mucosal site RT (mucosal RT) was done to 23 patients and 39 patients did not receive mucosal RT. Mucosal RT showed no significant effect on overall survival (OS) and locoregional recurrence (LRR). The location of primary site failure encountered during follow-up period was found to be unpredictable and 75% of patients with recurrence received successful salvage therapies. No significant differences in OS and LRR were found between patients treated to unilateral (n = 35) and bilateral neck irradiation (n = 21). Treatment of both necks resulted in significantly higher mucositis. Conclusions: We found no advantages in OS and LRR of patients with HNMUO when mucosal sites and bilateral neck node were included in the radiation target volume.

키워드

참고문헌

  1. Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998;20:739-44. https://doi.org/10.1002/(SICI)1097-0347(199812)20:8<739::AID-HED13>3.0.CO;2-0
  2. Klem ML, Mechalakos JG, Wolden SL, et al. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Int J Radiat Oncol Biol Phys 2008;70:1100-7. https://doi.org/10.1016/j.ijrobp.2007.07.2351
  3. Reddy SP, Marks JE. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys 1997;37:797-802. https://doi.org/10.1016/S0360-3016(97)00025-4
  4. Kamal M, Mohamed AS, Fuller CD, et al. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy. Cancer 2018;124:1415-27. https://doi.org/10.1002/cncr.31235
  5. Al Kadah B, Papaspyrou G, Linxweiler M, et al. Cancer of unknown primary (CUP) of the head and neck: retrospective analysis of 81 patients. Eur Arch Otorhinolaryngol 2017;274:2557-66. https://doi.org/10.1007/s00405-017-4525-8
  6. Shoushtari A, Saylor D, Kerr KL, et al. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:e83-91. https://doi.org/10.1016/j.ijrobp.2011.01.014
  7. Studer G, Huber GF, Holz E, Glanzmann C. Less may be more: nodal treatment in neck positive head neck cancer patients. Eur Arch Otorhinolaryngol 2016;273:1549-56. https://doi.org/10.1007/s00405-015-3634-5
  8. Muller von der Grun J, Tahtali A, Ghanaati S, Rodel C, Balermpas P. Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site: current status and challenges. Radiat Oncol 2017;12:82. https://doi.org/10.1186/s13014-017-0817-9
  9. Cuaron J, Rao S, Wolden S, et al. Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy. Head Neck 2016;38 Suppl 1:E426-31. https://doi.org/10.1002/hed.24013
  10. Beldi D, Jereczek-Fossa BA, D'Onofrio A, et al. Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys 2007;69:1051-8. https://doi.org/10.1016/j.ijrobp.2007.04.039
  11. Perkins SM, Spencer CR, Chernock RD, et al. Radiotherapeutic management of cervical lymph node metastases from an unknown primary site. Arch Otolaryngol Head Neck Surg 2012;138:656-61. https://doi.org/10.1001/archoto.2012.1110
  12. Cabrera Rodriguez J, Cacicedo J, Giralt J, et al. GEORCC recommendations on target volumes in radiotherapy for Head Neck Cancer of Unkown Primary. Crit Rev Oncol Hematol 2018;130:51-9. https://doi.org/10.1016/j.critrevonc.2018.07.006
  13. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours: results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000;55:121-9. https://doi.org/10.1016/S0167-8140(00)00172-9
  14. Nieder C, Gregoire V, Ang KK. Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 2001;50:727-33. https://doi.org/10.1016/S0360-3016(01)01462-6
  15. Weir L, Keane T, Cummings B, et al. Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol 1995;35:206-11. https://doi.org/10.1016/0167-8140(95)01559-Y
  16. Sinnathamby K, Peters LJ, Laidlaw C, Hughes PG. The occult head and neck primary: to treat or not to treat? Clin Oncol (R Coll Radiol) 1997;9:322-9. https://doi.org/10.1016/S0936-6555(05)80066-4
  17. Marcial-Vega VA, Cardenes H, Perez CA, et al. Cervical metastases from unknown primaries: radiotherapeutic management and appearance of subsequent primaries. Int J Radiat Oncol Biol Phys 1990;19:919-28. https://doi.org/10.1016/0360-3016(90)90013-A
  18. Wang Y, He SS, Bao Y, et al. Cervical lymph node carcinoma metastasis from unknown primary site: a retrospective analysis of 154 patients. Cancer Med 2018;7:1852-9. https://doi.org/10.1002/cam4.1458